- Safe Re-administration of Tumor Necrosis Factor-alpha (TNFalpha) Inhibitors in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Who Developed Active Tuberculosis on Previous Anti-TNFalpha Therapy
-
Suh YS, Kwok SK, Ju JH, Park KS, Park SH, Yoon CH
- KMID: 1796912
- J Korean Med Sci.
- 2014 Jan;29(1):38-42.
- doi: 10.3346/jkms.2014.29.1.38
There is no consensus on whether it is safe to re-administer tumor necrosis factor-alpha (TNFalpha) inhibitors in patients with rheumatoid arthritis (RA) or ankylosing spondylitis (AS) flared after withdrawal of... -
- CITED
-
- Close
- SHARE
-
- Close
- Chemotherapy induced liver abnormalities: an imaging perspective
-
Sharma A, Houshyar R, Bhosale P, Choi JI, Gulati R, Lall C
- KMID: 2069771
- Clin Mol Hepatol.
- 2014 Sep;20(3):317-326.
- doi: 10.3350/cmh.2014.20.3.317
Treating patients undergoing chemotherapy who display findings of liver toxicity, requires a solid understanding of these medications. It is important for any clinician to have an index of suspicion for... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Acarbose and Voglibose in Diabetes Patients Who Are Inadequately Controlled with Basal Insulin Treatment: Randomized, Parallel, Open-Label, Active-Controlled Study
-
Lee MY, Choi DS, Lee MK, Lee HW, Park TS, Kim DM, Chung CH, Kim DK, Kim IJ, Jang HC, Park YS, Kwon HS, Lee SH, Shin HK
- KMID: 1796920
- J Korean Med Sci.
- 2014 Jan;29(1):90-97.
- doi: 10.3346/jkms.2014.29.1.90
We studied the efficacy and safety of acarbose in comparison with voglibose in type 2 diabetes patients whose blood glucose levels were inadequately controlled with basal insulin alone or in... -
- CITED
-
- Close
- SHARE
-
- Close
